Month: June 2024
Tropical Storm Alberto makes landfall in Mexico; Texas faces flooding and heavy rain
A driveway leading to a home seen is covered in floodwater on June 19, 2024 in Surfside Beach, Texas. Storm Alberto, the first named tropical storm of the hurricane season, was located approximately 305 miles south-southeast of Brownsville, Texas and formed earlier today in the Southwestern Gulf of Mexico. Brandon Bell | Getty Images The […]
Read More
Catalyst calendar: Here’s a look at major events that could propel these 7 stocks higher
AI tech stocks have been on the rage on Wall Street. But here are some events that could lift other Club names higher in the weeks and months ahead. Source
Read More
Stocks creating the major moves midday: Gilead Sciences, Accenture, Trump Media, AMD and additional
Test out the providers building the major moves midday: Accenture — Shares popped 7.3% immediately after the consulting enterprise documented far more than $900 million in generative artificial intelligence bookings for its 3rd quarter, bringing the full to $2 billion for this fiscal year. Gilead Sciences — The biopharma stock surged 7.7% after the organization […]
Read More
CNBC’s Inside India newsletter: India Inc might not even need a Fed rate cut — but it wants one
A solar power plant in Tuticorin, India, on Wednesday, March 20, 2024. Bloomberg | Bloomberg | Getty Images This report is from this week’s CNBC’s “Inside India” newsletter which brings you timely, insightful news and market commentary on the emerging powerhouse and the big businesses behind its meteoric rise. Like what you see? You can […]
Read More
Be careful what you wish for: The S&P 500 typically falls after the first rate cut
Investors have long been hoping that the Federal Reserve will start cutting interest rates, but data shows that that outcome could create trouble for the equity market. On average, the S & P 500 is usually up 2% 65 days before the first cut from the central bank following a hiking cycle, according to data […]
Read More
This 30-calendar year-outdated produced $66,000 offering trash last 12 months. His finds include Fendi baggage and hundreds in hard cash
Leonardo Urbano, 30, sits on a sofa that was set out for disposal in Sydney. Leonardo Urbano They say a single man’s trash is one more man’s treasure. Without a doubt, Leonardo Urbano manufactured as much as 100,000 Australian dollars ($66,306) final calendar year rummaging by garbage piles in Sydney for hidden gems and promoting […]
Read More
Fast-food customers are shifting to casual-dining chains, Darden Restaurants CEO says
Customers arrive at an Olive Garden location in San Antonio, Texas. Callaghan O’Hare | Bloomberg | Getty Images Casual-dining chains are gaining customers who have grown frustrated with higher fast-food prices, Darden Restaurants CEO Rick Cardenas said on Thursday. While Darden itself hasn’t benefited from the shift, its competitors, like Chili’s owner Brinker International and […]
Read More
Amazon’s ditching the plastic air pillows in its bins
Amazon reported Thursday it has eradicated 95% of the plastic air pillows from its packaging in North The united states and will exchange them with paper fillers created from 100% recycled written content. It marks Amazon’s greatest plastic-packaging reduction hard work and will assistance it take away just about 15 billion plastic pillows annually. “We […]
Read More
Red flags that suggest a job posting doesn’t offer a ‘competitive salary’ as it claims, recruiters say
Job postings that claim to offer a “competitive salary” are on the rise, putting more onus on job seekers to suss out how much money they can expect from a new role. While you can figure out the salary range after a conversation or two, you might not want to get too far without having […]
Read More
Gilead’s twice-yearly shot to prevent HIV succeeds in late-stage trial
The logo of Gilead Sciences pharmaceutical company is seen in Oceanside, California, April 29, 2020. Mike Blake | Reuters Gilead‘s experimental twice-yearly medicine to prevent HIV was 100% effective in a late-stage trial, the company said Thursday. None of the roughly 2,000 women in the trial who received Gilead’s shot lenacapavir had contracted HIV by […]
Read More